RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $80,874 | +22.0% | 26,958 | 0.0% | 0.04% | +26.7% |
Q2 2023 | $66,317 | +8.8% | 26,958 | 0.0% | 0.03% | 0.0% |
Q1 2023 | $60,926 | -35.2% | 26,958 | 0.0% | 0.03% | -41.2% |
Q4 2022 | $94,083 | -90.6% | 26,958 | 0.0% | 0.05% | -91.0% |
Q3 2022 | $998,000 | +94.9% | 26,958 | 0.0% | 0.56% | +102.9% |
Q2 2022 | $512,000 | -29.7% | 26,958 | 0.0% | 0.28% | -12.0% |
Q1 2022 | $728,000 | +19.9% | 26,958 | 0.0% | 0.32% | +26.9% |
Q4 2021 | $607,000 | -14.1% | 26,958 | 0.0% | 0.25% | -23.4% |
Q3 2021 | $707,000 | -18.1% | 26,958 | 0.0% | 0.32% | -19.2% |
Q2 2021 | $863,000 | -9.1% | 26,958 | 0.0% | 0.40% | -16.6% |
Q1 2021 | $949,000 | +9.7% | 26,958 | 0.0% | 0.48% | +1.7% |
Q4 2020 | $865,000 | -14.7% | 26,958 | 0.0% | 0.47% | -25.4% |
Q3 2020 | $1,014,000 | -15.9% | 26,958 | 0.0% | 0.64% | -22.9% |
Q2 2020 | $1,206,000 | – | 26,958 | – | 0.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
RA Capital Management | 781,290 | $29,392,000 | 0.54% |
TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |